Inflammatory factors contribute to depression and its comorbid conditions. (Q48351417)

10 February 2018

title

Inflammatory factors contribute to depression and its comorbid conditions. (English)

1 reference

10 February 2018

author name string

Hymie Anisman

series ordinal

1

1 reference

10 February 2018

Shawn Hayley

series ordinal

2

1 reference

10 February 2018

publication date

2 October 2012

1 reference

10 February 2018

published in

Science Signaling

1 reference

10 February 2018

volume

5

1 reference

10 February 2018

issue

244

1 reference

10 February 2018

page(s)

pe45

1 reference

10 February 2018

Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Is depression an inflammatory disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Inflammation selectively enhances amygdala activity to socially threatening images

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Inflammation and depression: why poststroke depression may be the norm and not the exception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Role of IL-1 in poststroke depressive-like behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Interferon-alpha effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Inflammation-associated depression: from serotonin to kynurenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

A neurotrophic model for stress-related mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Immune modulation of learning, memory, neural plasticity and neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Signaling pathways underlying the rapid antidepressant actions of ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Behavioral control of the stressor modulates stress-induced changes in neurogenesis and fibroblast growth factor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Dysregulation of the fibroblast growth factor system in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Elevated macrophage migration inhibitory factor (MIF) is associated with depressive symptoms, blunted cortisol reactivity to acute stress, and lowered morning cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Depressive symptoms predict exaggerated inflammatory responses to an in vivo immune challenge among pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003579

10.1126/SCISIGNAL.2003579

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

23033537

1 reference

10 February 2018